Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
EMBC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$9.93 - $21.48
Previous CloseN/A
Volume119.84K
Average Volume (3M)500.59K
Market Cap
$732.49M
Enterprise Value$2.59B
Total Cash (Recent Filing)$210.00M
Total Debt (Recent Filing)$1.58B
Price to Earnings (P/E)12.5
Beta0.92
Next Earnings
May 09, 2025EPS Estimate
0.53Last Dividend Ex-Date
Feb 28, 2025Dividend Yield4.66%
Share Statistics
EPS (TTM)1.00
Shares Outstanding58,134,434
10 Day Avg. Volume695,827
30 Day Avg. Volume500,594
Financial Highlights & Ratios
PEG Ratio2.73
Price to Book (P/B)N/A
Price to Sales (P/S)0.68
Price to Cash Flow (P/CF)-35.30
P/FCF Ratio0.00
Enterprise Value/Market Cap3.53
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.52
Enterprise Value/Ebitda11.70
Forecast
1Y Price Target
$26.00Price Target Upside106.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Embecta Corporation News
PremiumCompany Announcements
Embecta Corporation Reports Q1 2025 Earnings Amid Strategic Shifts
PremiumCompany Announcements
Embecta Corp’s Earnings Call: Growth Amid Challenges
PremiumPre-Earnings
Is EMBC a Buy, Before Earnings?
PremiumCompany Announcements
Embecta Corp Appoints Anthony Roth as VP and CAO
---
Bulls Say, Bears Say
Bulls Say
Cost SavingsThe organizational restructuring plan, along with the discontinuation of the patch pump program, is expected to generate annualized pre-tax cost savings of $60-$65M.
EarningsEmbecta reported an impressive F4Q24 quarter, beating expectations on adjusted revenue, margins and EPS, while setting FY2025 preliminary adj. EBITDA and adj. EPS guidance well ahead of expectations.
Bears Say
Revenue GuidanceRevenue guidance for 2025 is set below current market expectations, indicating a potential decline in financial performance.
---
Ownership Overview
2.26% Insiders
28.99% Mutual Funds
24.90% Other Institutional Investors
15.73% Public Companies and Individual Investors
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $9.93 and its highest was $21.48 in the past 12 months.
What is Embecta Corporation’s market cap?
Embecta Corporation’s market cap is $732.49M.
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is May 09, 2025 which is in 64 days.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on Feb 06, 2025. The company reported $0.65 earnings per share for the quarter, beating the consensus estimate of $0.493 by $0.157.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Undervalued.
Does Embecta Corporation pay dividends?
Embecta Corporation pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 4.66%. See more information on Embecta Corporation dividends here
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is 0.53.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 58,134,434 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $0.65 in its last earnings report, beating expectations of $0.493. Following the earnings report the stock price went down -2.611%.
Which hedge fund is a major shareholder of Embecta Corporation?
Currently, no hedge funds are holding shares in EMBC
---
Embecta Corporation Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$26.00 (106.35% Upside)
$26.00 (106.35% Upside)
Blogger Sentiment
Bullish
EMBC Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 291.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $126.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 17.5%
Last 30 Days ▲ 17.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.48%
12-Months-Change
Fundamentals
Return on Equity
-10.61%
Trailing 12-Months
Asset Growth
-5.61%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
---
EMBC Company Deck
---
EMBC Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment. While Embecta Corp. showcased strategic initiatives for growth, debt reduction, and restructuring progress, the company reported declines in revenue and gross margins due to ERP implementations and distributor rebalancing. The positive aspects of strategic growth and margin improvements are tempered by significant revenue challenges.Read More>---
EMBC Stock 12 Month Forecast
Average Price Target
$26.00
▲(106.35% Upside)
Technical Analysis
Best Analysts Covering EMBC
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+16.50%
assigned a sell rating 3 months ago
Copying Travis Steed's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +16.50% per trade.
---